-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOMARIN PHARMACEUTICAL INC - EXPECTS $230-$260 MLN ASSET WRITE-DOWN FOR ROCTAVIAN IN Q4- SEC FILING

Reuters·01/12/2026 21:46:08

Please log in to view news